Live Breaking News & Updates on Trial Topline Results

Stay updated with breaking news from Trial topline results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Mansfield , Nunavut , Canada , New-york , United-states , Darren-opland , Herriot-tabuteau , Mark-jacobson , Development-pipeline , Company-new-drug-application , Corporate-communications , Drug-administration

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309% ....

New-york , United-states , Ottawa , Ontario , Canada , Canadian , Joe-oconnor , Barbara-shecter , Goldy-hyder , Darren-opland , Mark-jacobson , Herriot-tabuteau

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

20.02.2024 - Total 4Q and full year 2023 net product revenue of $71.5 million and $204.9 million, respectively, representing year-over-year growth of 193% and 309% Auvelity 4Q and full year 2023 net product sales of $49.0 million and $130.1 million, . ....

New-york , United-states , Herriot-tabuteau , Mark-jacobson , Darren-opland , Axsome-therapeutics-inc , Drug-administration , Development-pipeline , World-trade-center , Nasdaq , Corporate-communications , Axsome-therapeutics

Axsome Eyes Phase 3 Trial Milestones for Sleep Disorder Drugs

Axsome detailed anticipated milestones for investigational drugs for narcolepsy and EDS associated with shift work disorder. ....

United-states , Drug-administration , Axsome-therapeutics-inc , Us-drug-enforcement-agency-on , Development-pipeline-anticipated-milestones , Enforcement-agency , Orphan-drug , Pipeline-anticipated , Trial-topline-results , Trial-initiations ,

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones

Preliminary total 4Q and full year 2023 net product revenue of $71 million and $204 million, respectively Auvelity preliminary 4Q and full year 2023 net product sales of $49 million and $130 million,. ....

New-york , United-states , Japan , China , Darren-opland , Herriot-tabuteau , Mark-jacobson , Nasdaq , Corporate-communications , Sk-biopharmaceuticals-co-ltd , Us-drug-enforcement-agency-on , Drug-administration